Thu, Apr 17, 2014, 4:20 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Bergamo Acquisition Corp. Message Board

  • francpienaar francpienaar Jul 10, 2013 11:49 AM Flag

    BGMO - buy all you can...10 bagger!!

    Big move coming IMO

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Shawn K. Singh, VistaGen's Chief Executive Officer, stated, "I met with Autilion's team earlier this week, and we have been working closely with them since signing our agreement in April. We are confident and excited about completing this transformative financing. Building on the positive developments in our labs presented during the Annual Meetings of the Society of Toxicology and International Society of Stem Cell Research in March and this month, respectively, we look forward to accelerating our lead programs towards valuable outcomes for our shareholders."

      Sentiment: Strong Buy

    • BIG MOVE TO THE GRAY MARKET!!!!!!!

      GO LUCK TO YOU LOSERS WHO BOUGHT THE CHEAPIES OF A WORTHLESS SCAM!!!!!!!

      GOING TO .05 FOR A TRILLION SHARES TOTAL MARKET CAP!!

    • Bought 200k shares today which I will sell at .05, easy 5 bagger!!

      Sentiment: Strong Buy

      • 4 Replies to dollardominator333
      • For 72 million shares of restricted common stock

        VistaGen signed a strategic financing agreement with the European subsidiary of Bergamo Acquisition Corp., a global diversified investment holding company.

        VistaGen plans to use proceeds of the financing to accelerate and expand its stem cell technology-based drug rescue programs. Using its innovative CardioSafe(TM) 3D and LiverSafe(TM) 3D bioassay systems and modern medicinal chemistry, VSTA is focused on generating new, safer, proprietary variants (Drug Rescue Variants) of once-promising small molecule drug candidates discontinued in development by large pharmaceutical companies due to heart or liver safety issues. VSTA also plans to advance new pilot nonclinical regenerative cell therapy programs and certain other emerging commercial opportunities related to its Human Clinical Trials in a Test Tube(TM) platform

        Sentiment: Strong Buy

      • Vistagen therapeutics on canadas largest news broadcaster

        Sentiment: Strong Buy

      • As real and true as the Heart Attack, that people who don`t own shares are going to have HEHEHEHE !!!!

        Quote:
        However, in the event that an accountant finds erroneous, misleading or incomplete information in the financial statements they must notify management or abandon their involvement in assessing the company’s financial statements. The accountant who is appointed to compile a company’s financial statement must be familiar with the company and its main business processes.

        DID THE INDEPENDENT ACCOUNTING FIRM OF L.L.BRADFORD ABANDON THE FINANCIAL REPORT ( NO )

        THE INDEPENDENT ACCOUNTING FIRM OF L.L.BRADFORD PUT THE FINANCIAL REPORT ON THEIR OWN LETTER HEAD ( YES ) !!!!

        DID THE INDEPENDENT ACCOUNT FROM OF L.L.BRADFORD TRAVEL TO SWITZERLAND TO VERIFY THE NUMBERS ( YES )

        DID THE INDEPENDENT ACCOUNT FROM OF L.L.BRADFORD TRAVEL TO LONDON TO VERIFY THE NUMBERS ( YES )

        For the period from January 1, 2012, through September 17, 2012, the company reported net income of $88,439,000, or $0.53 per share, on consolidated revenues of $283,952,000.

        Sentiment: Strong Buy

      • Nice buy - I think you'll make 10 times your money.

        Sentiment: Strong Buy

 
BGMO
0.0010.000(0.00%)Apr 9 10:32 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.